OP
Orikolodatte Perinchery Ravindran Nair
About Orikolodatte Perinchery Ravindran Nair
Data last updated:
Orikolodatte Perinchery Ravindran Nair is an Additional Director at Glucolabs Healthcare Private Limited (since 2022). The company operates in Pharma. Glucolabs Healthcare Private Limited reported revenue of ₹80.3 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Glucolabs Healthcare Private Limited U24231MP2021PTC054737 | Additional Director | 23 May 2022 | 2021 | ₹80.3 Lakh (FY 2025) | Active |
Board colleagues of Orikolodatte Perinchery Ravindran Nair
| Name | DIN | Company | Designation |
|---|---|---|---|
| Babita Saxena | 09052347 | Glucolabs Healthcare Private Limited | Director |
| Deepak Sharma | 09265909 | Glucolabs Healthcare Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Orikolodatte Perinchery Ravindran Nair
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Orikolodatte Perinchery Ravindran Nair
Orikolodatte Perinchery Ravindran Nair currently holds 1 directorship: Glucolabs Healthcare Private Limited (Additional Director, since 23 May 2022, revenue ₹80.3 Lakh (FY 2025)).
Orikolodatte Perinchery Ravindran Nair was first appointed on 23 May 2022 as Additional Director at Glucolabs Healthcare Private Limited.
The current boards of Orikolodatte Perinchery Ravindran Nair's companies include Babita Saxena (Glucolabs Healthcare Private Limited), Deepak Sharma (Glucolabs Healthcare Private Limited).